A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery.
Ayesha KarimiDan LindfieldAndrew M J TurnbullChrysostomos DimitriouBhairavi BhatiaMahmoud RadwanPieter GouwsAbdul HanifudinNishani AmerasingheAby JacobPublished in: Eye (London, England) (2018)
Xen reduces IOP and medications at 18 months. Adverse events are uncommon. Careful postoperative surveillance and low threshold for bleb management is needed. Xen is safe and effective in mild to moderate glaucoma.